Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

NCT07316595 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HSCT
Nijmegen Breakage Syndrome
Treosulfan Based Conditioning

Interventions

DRUG: Treosulfan (Treo)

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]